Angel News

Back to Homepage

11th February 2020

Foresight invests £500k in Novel Technologies to commercialise its SILVERbac antimicrobial technology

Foresight has made a £500,000 growth capital investment into Novel Technologies Holding Limited, developers of antimicrobial technology SILVERbac.  This is the third investment made by the £20 million Foresight Scottish Growth Fund which is financed by the Scottish Growth Scheme through a combination of Scottish Government funds and the European Regional Development Fund (ERDF), and is part of a wider £2.1 million funding round for NTH.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage